Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ester-E sales

This article was originally published in The Tan Sheet

Executive Summary

Retail sales for Zila's Ester-E vitamin E branded ingredient increased 35% in the 12-week period ended March 19 over the previous year, despite the overall category is 42%, Zila states May 4. The downward trend for vitamin E is the result of publicity surrounding recently published negative studies on the antioxidant. The firm's nationally airing TV and radio ads for branded products Ester-E and Ester-C helped increase revenue by 14% to $9.8 mil. during the firm's fiscal second quarter (1"The Tan Sheet" March 21, 2005, In Brief)...

You may also be interested in...



HSA resources

Fort Lee, N.J.-based Information Strategies offers The Consumer's Guide To Health Savings Accounts book and 1HSAfinder.com website to inform consumers on HSA options. The book "helps readers become better-informed healthcare consumers, critical to utilizing this new approach to healthcare," the firm says. More than half of all healthcare policies will involve HSAs by 2010, Information Strategies predicts, claiming more Americans established the accounts in January than in all of 2004...

Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company

The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.

Synthekine Joins Quest To Tame IL-2 In Cancer Therapies

First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098165

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel